Business · 22/02/2018Updated: 10/17/2026 · 1 min read
Pfizer Subsidiary Parke-Davis Withdraws FDA Approval for 38 New Drugs and 43 Generic Medications
Summary
The US Food and Drug Administration (FDA) is withdrawing approval for 38 new prescription drug applications and 43 generic medication applications from various applicants, following written notifications from the applicants that the drugs are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →